Clinical observations of bone marrow transfusion for promoting bone marrow reconstruction after chemotherapy for AIDS-related lymphoma

Table 1 Comparison of changes in CD4⁺T lymphocytes (cells/μl) after bone marrow transfusion vs without bone marrow transfusion

Group	before chemotherapy	first course	third course	sixth course	1 year after chemotherapy
CT	132.31 ± 79.88	107.81 ± 75.34	110.81 ± 69.38	101.08 ± 78.61	168.20 ± 83.66
ABM-MVI	112.00 ± 77.69	105.63 ± 72.29	105.25 ± 66.71	122.75 ± 72.38	209.43 ± 74.17
ABM-PI p-value	162.50 ± 75.87 0.475	163.13 ± 70.14 0.149	184.63 ± 79.78^ab 0.04	221.75 ± 50.10^ab 0.001	282.14 ± 57.76^ab 0.004

p-value: one-way ANOVA (P < 0.05 means there was statistically significant in the three groups)
a: the difference was statistically significant between ABM groups (ABM-MVI or ABM-PI)
and CT group (^aP < 0.05); b: the difference was statistically significant between the two ABM groups, (^bP < 0.05)

ISSN: 1471-2172